Azitra Inc Employee Directory
Biotechnology ResearchConnecticut, United States11-50 Employees
Azitra, Inc. is a clinical-stage biotechnology company focused on precision dermatology. Its lead programs employ engineered strains of Staphylococcus epidermidis to address skin diseases, with ATR-12 aimed at Netherton syndrome and ATR-04 targeting EGFR inhibitor–associated skin toxicity. These efforts are built on a proprietary platform of engineered proteins and topical live biotherapeutics that includes a library of roughly 1,500 bacterial strains. The company was founded in 2014 by scientists from Yale University and is based in Branford, Connecticut. It collaborates with leading researchers in dermatology, microbiology, and genetic engineering to advance work in atopic dermatitis and other targeted orphan indications. In 2026, Azitra presented new preclinical data from its ATR-01 program at the Annual Meeting of the American Society of Gene & Cell Therapy.